BA3361, a NextGen CAB ADC Targeting Nectin4
Conditionally Active Biologic (CAB) ADCs with Novel NextGen Linker Show Improved Efficacy and Safety
A Novel Dual CAB Nectin-4 x CD3 Bispecific Antibody Targeting Solid Tumors
A Novel Dual-Cab Nectin-4 X CD3 Bispecific Antibody Targeting Solid Tumors
NextGen Conditionally Active Biologic (CAB) ADCs: Improved Stability and Safety
NextGen Conditionally Active Biologic (CAB) ADCs: Improved Stability and Safety
Novel Conditionally Active Bispecific T Cell Engagers Targeting Solid Tumors
Novel conditionally active ADCs (CAB ADCs): A novel class of molecules targeting solid tumors
